Interview with Renê Delsin, General Manager, Roche Chile
How would you assess Roche’s performance in Chile since its establishment and how has your portfolio developed in the Chilean market? Next year marks Roche’s 40th anniversary in Chile, which…
Address: Avenida Cerro El Plomo 5630,Las Condes, Santiago 7550000
Tel: +56 2 4413200
Web: http://www.roche.cl/portal/roche-chile/inicio
Roche plays a pioneering role in healthcare. As an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, they contribute on a broad range of fronts to improving people’s health and quality of life. Roche is providing the first products that are tailored to the needs of specific patient groups. Our mission today and tomorrow is to create added value in healthcare by focusing on our expertise in diagnostics and pharmaceuticals. The company has also been developing its biotechnology through its wholly-owned subsidiary Genentech.
In Chile, Roche specializes in its oncology products that represent 50% of the company’s revenue.
Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is active in other major therapeutic areas with a high medical need such as autoimmune diseases, inflammatory diseases, virology, metabolic disorders and diseases of the central nervous system.
Oncology
How would you assess Roche’s performance in Chile since its establishment and how has your portfolio developed in the Chilean market? Next year marks Roche’s 40th anniversary in Chile, which…
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a working group that is…
Medtronic, world’s largest medical technology company, opened a direct operation in Chile in October 2013. Gonzalo Valdebenito elaborates on the affiliate’s first steps in the country and the mission he…
Cells for Cells is the first Chilean biotechnology company engaged in the research, development and commercialization of innovative cell therapies based on adult stem cells. In line with the company’s…
“We have implemented a strategic plan with a key objective to put Chile on the map. We are seeing major market opportunities in the country”, says Carlos Cicogna, Managing Director,…
Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses the importance of the affiliate’s role in…
Raúl Sánchez, general manager of Peri Logistics speaks about the main features that distinguish Peri Logistics as a pharmaceutical logistics operator. Celebrating its 10th year anniversary this year, the company…
João Simões, Head of Integration at Grunenthal Chile, discusses Grunenthal’s acquisition of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its…
“70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, Vicepresidente Ejecutivo of the association that represents the innovative…
Rodrigo Azócar Ibaceta, general manager at Laboratorios Raffo Chile speaks about Raffo’s development on the Chilean market. Part of the prestigious GP Pharm’s group, Raffo is one of the fastest…
Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans. Over the past years Janssen successfully launched several products to the Chilean market…
Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile. It is the first center of excellence that Pfizer is building in Chile…
Our business model is new in the Chilean market and enables us with great flexibility and allows us to focus on demand generation. For Ferrer this is a great window…
See our Cookie Privacy Policy Here